Defunct Company
Total Trials
9
As Lead Sponsor
4
As Collaborator
5
Total Enrollment
3,032
NCT01610063
Evaluation of an Antidepressant Pharmacogenomic Algorithm in an Outpatient Clinical Setting
Phase: N/A
Role: Collaborator
Start: Jan 31, 2009
Completion: May 31, 2013
NCT01261364
Pharmacogenetic-Directed Treatment for Major Depression
Role: Lead Sponsor
Start: Sep 30, 2009
Completion: Sep 30, 2011
NCT02479464
Clinical Impact of the Antidepressant Pharmacogenomic Algorithm in an Outpatient Therapy-based Clinical Setting
Start: Oct 31, 2009
Completion: Aug 31, 2014
NCT01632267
Retrospective Analysis of Outcomes With a Pharmacogenomic Algorithm
Start: Jan 31, 2011
NCT02109939
Genomics Used to Improve DEpression Decisions
Start: Apr 30, 2014
Completion: Jul 31, 2017
NCT02466477
Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder
Phase: Phase 4
Start: Jun 30, 2015
Completion: Sep 30, 2019
NCT02573168
Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With Antipsychotics
Start: Jan 31, 2016
Completion: Sep 30, 2020
NCT03537547
Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder
Start: May 4, 2018
Completion: Aug 19, 2019